cabazitaxel
cabazitaxel is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Jevtana. Available dosage form: kit.
Drug Details
- Generic Name
- cabazitaxel
- Brand Names
- Jevtana
- Application Number
- NDA201023
- Sponsor
- Sanofi-Aventis U.S. LLC
- NDC Codes
- 1
- Dosage Forms
- KIT
- Routes
- N/A
- Active Ingredients
- N/A
Indications and Usage
1 INDICATIONS AND USAGE JEVTANA ® is indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing treatment regimen. JEVTANA is a microtubule inhibitor indicated in combination with prednisone for treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing treatment regimen. ( 1 )